T1	Participants 335 416	Thai adults was conducted in 3 hospitals in northern Thailand during 2002 to 2003
T2	Participants 422 600	eligible subjects were HIV-infected Thai adults who had never received anti-retrovirals, had a Karnofski Performance Score (KPS) of > or = 70, and had no opportunistic infections
T3	Participants 1073 1143	60 evaluable subjects, 40 in the SH group and 20 in the placebo group,
